Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss

PURPOSE: To establish a high-risk prediction model for aromatase inhibitor-associated bone loss (AIBL) in patients with hormone receptor-positive breast cancer. METHODS: The study included breast cancer patients who received aromatase inhibitor (AI) treatment. Univariate analysis was performed to id...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Meiling, Zhou, Yue, Yin, Yulian, Jin, Lan, Chen, Hongfeng, Meng, Tian, He, Binjun, Wu, Jingjing, Ye, Meina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174287/
https://www.ncbi.nlm.nih.gov/pubmed/37182163
http://dx.doi.org/10.3389/fonc.2023.1182792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174287/
https://www.ncbi.nlm.nih.gov/pubmed/37182163
http://dx.doi.org/10.3389/fonc.2023.1182792

Ejemplares similares